Inhibitory effect of luteolin on MKN-45 tumorg gastric cells: The role of nucleoside-diphosphate kinases, cofilin and actin proteins

authors:

avatar Zahra Tahmasebi , avatar Maziar Akhavan , * , avatar Sepideh Torabi , avatar Naser Abbasi , avatar Elham Sarhadi , avatar NAsim Hatam nejadian


how to cite: Tahmasebi Z, Akhavan M, Torabi S, Abbasi N, Sarhadi E, et al. Inhibitory effect of luteolin on MKN-45 tumorg gastric cells: The role of nucleoside-diphosphate kinases, cofilin and actin proteins. koomesh. 2017;19(3):e152907. 

Abstract

Introduction: Luteolin is an important plant extract. This shows anti-inflammatory, inhibition of cell growth, induction of apoptosis and inhibition of metastasis. Gastric cancer is one of the most common cancers in the world. Also metastasis is widespread in this kind of cancer and late diagnosis is a cause of patient;#39s death.  Cofilin, actin and nucleoside-diphosphate kinases (NDPK) are important in cell death and metastasis. In this study the effect of luteolin on MKN-45 gastric carcinoma cells was evaluated. Materials and Methods: At first the cells were cultured and then for 48 hours were cultured with the drug concentration. Then the cells where collected and their protein were extracted and analyzed using 2D electrophoresis and separated on the basis of their molecular mass and PI. After that these samples were used for determine the amino acid sequence by MOLDI-TOF. Results: The growth rate of MKN-45 inhibited under influence of luteolin, this means increasing Apoptosis. Based on the results presented here by identification of protein spots by MOLDI-TOF mass spectrometry the expression of three protein cofilin, actin and NDPK has been decreased by luteolin. Conclusion: It seems that the anti- tumoral effect of luteolin is expressed through three proteins cofilin, actin and NDPK in gastric cancer cells

References

  • 1.

    Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001; 90: 157-177.

  • 2.

    Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 2004; 50: 1-7.

  • 3.

    Liesveld JL, Abboud CN, Lu C, McNair C, Menon A, Smith A, et al. Flavonoid effects on normal and leukemic cells. Leuk Res 2003; 27: 517-527.

  • 4.

    Matsuo M, Sasaki N, Saga K, Kaneko T. Cytotoxicity of flavonoids toward cultured normal cells. Biol Pharm Bull 2005; 28: 253-259.

  • 5.

    Lin Y, Shi R, Wang X, Shen HM. Luteolin, a flavonoid with potential for cancer prevention and therapy. Current Cancer Drug Targets 2008; 8: 634-646.

  • 6.

    Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 2013; 14: e535-547.

  • 7.

    Millard TH, Behrendt B, Launay S, Ftterer K, Machesky LM. Identification and characterisation of multiple forms of actin. Cell 1976; 9: 793-805.

  • 8.

    Yokdang N, Nordmeier S1, Speirs K1, Burkin HR1, Buxton IL. Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis. Integr Cancer Sci Ther 2015; 2: 192-200.

  • 9.

    Almgren MA, Henriksson KC, Fujimoto J, Chang CL. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol Cancer Res 2004; 2: 387-394.

  • 10.

    Yokdang N, Tellez JD, Tian H, Norvell J, Barsky SH, Valencik M, Buxton IL. A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling. Br J Cancer 2011; 104: 1628-1640.

  • 11.

    Snider NT, Altshuler PJ, Omary MB.. Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins. Naunyn Schmiedebergs Arch Pharmacol 2015; 388: 189-197.

  • 12.

    Castro MA, Dal-Pizzol F, Zdanov S, Soares M, Mller CB, Lopes FM, et al. CFL1 expression levels as a prognostic and drug resistance marker in no small cell lung cancer. Cancer 2010; 116: 3645-3655.

  • 13.

    Mller CB, de Barros RL, Castro MA, Lopes FM, Meurer RT, Roehe A, et al. Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort. J Cancer Res Clin Oncol 2011; 137: 1309-1316.

  • 14.

    Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004; 64: 8585-8594.

  • 15.

    Abbasi N, Akhavan MM, Rahbar-Roshandel N, Shafiei M. The effects of low and high concentrations of luteolin on cultured human endothelial cells under normal and glucotoxic conditions: involvement of integrin-linked kinase and cyclooxygenase-2. Phytother Res 2014; 28: 1301-1307.

  • 16.

    Obrdlik A, Percipalle P. The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation. Nucleus 2011; 2: 72-79.

  • 17.

    Bamburg JR, Wiggan OP. ADF/cofilin and actin dynamics in disease. Trends Cell Biol 2002; 12: 598-605.

  • 18.

    Li R, Wang X, Zhang XH, Chen HH, Liu YD. Ursolic acid promotes apoptosis of SGC-7901 gastric cancer cells through ROCK/PTEN mediated mitochondrial translocation of cofilin-1. Asian Pac J Cancer Prev 2014; 15: 9593-9597.

  • 19.

    Sidani M, Wessels D, Mouneimne G, Ghosh M, Goswami S, Sarmiento C, et al. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J Cell Biol 2007; 179: 777-791.

  • 20.

    Lin YC, Tsai PH, Lin CY, Cheng CH, Lin TH, Lee KP, et al. Impact of Flavonoids on Matrix Metalloproteinase Secretion and Invadopodia Formation in Highly Invasive A431-III Cancer Cells. PLoS One 2013; 8: e71903.

  • 21.

    E L Omri A, Han J, Ben Abdrabbah M, Isoda H. Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells. Cytotechnology 2012; 64: 231-240.

  • 22.

    Lee HZ, Yang WH, Bao BY, Lo PL. Proteomic analysis reveals ATP-dependent steps and chaperones involvement in luteolin-induced lung cancer CH27 cell apoptosis. Eur J Pharmacol 2010; 642: 19-27##.